Previous studies demonstrated that NAFLD-induced hepatic inflammation and HCC development were associated with CD4+ T cell depletion in the liver due to increased ROS production and apoptosis [13]. Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.